Histogen Inc
OTC:HSTOQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Histogen Inc
OTC:HSTOQ
|
US |
Balance Sheet
Balance Sheet Decomposition
Histogen Inc
Histogen Inc
Balance Sheet
Histogen Inc
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
3
|
4
|
4
|
10
|
14
|
58
|
16
|
12
|
2
|
7
|
19
|
12
|
|
| Cash Equivalents |
3
|
4
|
4
|
10
|
14
|
58
|
16
|
12
|
2
|
7
|
19
|
12
|
|
| Short-Term Investments |
14
|
4
|
52
|
27
|
23
|
19
|
59
|
29
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
3
|
0
|
1
|
3
|
1
|
|
| Total Current Assets |
17
|
8
|
57
|
38
|
38
|
80
|
79
|
47
|
2
|
8
|
22
|
13
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
2
|
3
|
1
|
0
|
2
|
1
|
1
|
|
| Total Assets |
17
N/A
|
8
-52%
|
57
+599%
|
38
-32%
|
40
+3%
|
82
+107%
|
82
0%
|
49
-40%
|
3
-94%
|
15
+411%
|
27
+82%
|
19
-30%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
1
|
1
|
1
|
3
|
3
|
5
|
12
|
6
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
1
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
31
|
14
|
10
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
1
|
3
|
4
|
4
|
40
|
28
|
19
|
1
|
3
|
2
|
1
|
|
| Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
21
|
13
|
3
|
0
|
5
|
5
|
4
|
|
| Total Liabilities |
3
N/A
|
3
-8%
|
4
+49%
|
5
+37%
|
5
-1%
|
61
+1 066%
|
54
-11%
|
21
-60%
|
1
-96%
|
7
+661%
|
6
-15%
|
5
-23%
|
|
| Equity | |||||||||||||
| Common Stock |
64
|
64
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
0
|
0
|
0
|
|
| Retained Earnings |
50
|
59
|
74
|
97
|
121
|
151
|
168
|
187
|
44
|
63
|
78
|
88
|
|
| Additional Paid In Capital |
0
|
0
|
128
|
130
|
155
|
172
|
196
|
214
|
7
|
71
|
99
|
103
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
14
N/A
|
6
-61%
|
53
+854%
|
33
-37%
|
35
+4%
|
22
-37%
|
28
+28%
|
27
-2%
|
2
-93%
|
8
+293%
|
21
+170%
|
14
-32%
|
|
| Total Liabilities & Equity |
17
N/A
|
8
-52%
|
57
+599%
|
38
-32%
|
40
+3%
|
82
+107%
|
82
0%
|
49
-40%
|
3
-94%
|
15
+411%
|
27
+82%
|
19
-30%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
|
| Preferred Shares Outstanding |
79
|
79
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|